Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
When Hardcore Pharma Investors Meet Enthusiastic Oncologists
This article is for subscribers only. Welcome back to Bloomberg's Health Monitor, a weekly look at the boardroom decisions, scientific advances and policy fights shaping the future of medicine. Sign up now if you're not already on the list. The…
Reed Hastings says Big Tech should get used to being hated - like Big Pharma
Reed Hastings thinks the tech industry has some Big Pharma energy. During an interview with 'On with Kara Swisher,' released on Monday, the Netflix founder and former co-CEO responded to questions about the unpopularity of Silicon Valley…
Should You Buy Royalty Pharma Stock Before Nov. 4?
Royalty Pharma (RPRX +1.64%) will report Q3 2026 earnings pre-market on Nov. 4. After pulling back in September due to a major setback with one of its drug candidates, the pharmaceutical royalty holding company's shares have been soaring back…
Economic Times Reports Piramal Pharma Led Four-Stock RSI Screen
The Economic Times reported that Piramal Pharma Limited led a four-stock Indian momentum screen on Oct. 28, when each selected share rose more than 6%. The outlet put Piramal Pharma's Relative Strength Index (RSI) at 71.93, compared with 49.11…
MAGA Senator Sure Picked Perfect Time to Buy Pharma Stock
Senator Roger Marshall made a conveniently timed stock purchase in 2018—but his position on the Health, Education, Labor, and Pensions, or HELP, Committee could juice the deal even more. Eight years ago on November 8, when he was still a…
Belgium's deputy PM wants to use 'trade bazooka' on US over pharma threats
The Trump administration has been pressuring European governments to pay more for medicines under its “most-favored-nation” policy as it seeks to bring American drug prices into line with those in other wealthy countries. Washington…
Swiss stock market climbs to new all-time high
On Thursday, the blue-chip stocks provided support for the SMI. Shares in the pharmaceutical group Novartis rose by 2% at around 9:50 am, those of the food giant Nestlé by 1% and those of the pharmaceutical company Roche by 0.5%. By…
Swiss railways plans CHF7 billion digital upgrade
The mid-terms and democracy, a new national park, and political hamburgers Read more: The mid-terms and democracy, a new national park, and political hamburgers Switzerland, China and Germany's mistakes Read more: Switzerland, China and Germany's…
Urogen Pharma (URGN) Projected to Announce Quarterly Earnings on Wednesday
Urogen Pharma (NASDAQ:URGN - Get Free Report) will likely be releasing its Q3 2026 results before the market opens on Wednesday, November 4th. Analysts expect Urogen Pharma to announce earnings of $0.10 per share and revenue of $90.58 million for…
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Breaks Above 50-Day Moving Average - Here's Why
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) passed above its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $70.70 and traded as high as $71.18. BridgeBio Pharma shares last traded at $70.82…
Spyglass Pharma (NASDAQ:SGP) Sets New 12-Month High - Still a Buy?
Shares of Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as $32.85 and last traded at $33.1310, with a volume of 105,033 shares. The stock had previously closed at $30.90.
Three questions that reveal whether your company controls its AI
AI is becoming business infrastructure, but many companies still don't control it. That control depends on the choices companies retain, the business context they own, and the accountability they establish for results. You can test all three by…
RFK Jr. Allows Unapproved Peptides on the Market
Health Secretary Robert F. Kennedy Jr. is temporarily allowing six unapproved peptides on the market, despite warnings from government scientists that there isn't enough evidence to prove they are safe or effective. In a policy released Wednesday…
Q2 Results 29th Oct Live: Coal India, Asian Paints, IndiGo, Trent, Laurus Labs, Ambuja Cements, Godrej Consumer, Welspun Corp, Apar Industries, Motilal Oswal, Blue Star, Strides Pharma, Milky Mist to announce Q2 results, Adani Ports, Hyundai, PVR Inox, Chola Finance, Meesho, Satin Creditcare, Birlas
Q2 Results Today, 29th October 2026 Live Updates: Find all the latest Q2 results 2026 updates of Twentyfirst Century Management Services, 3i Infotech, Archean Chemical Industries, Anlon Healthcare, Alchemist Corporation, Alivus Life Sciences…
Healthcare's AI race heats up
Winning is all about losing when it comes to weight-loss drugs. Eli Lilly thinks it has a REAL loser on its hands. The pharma giant published results from its first clinical trial pitting retatrutide, a next-generation injectable medication…
Receive a Daily briefing on Pharma Industry News
Get Started